Sumitomo Chemical: core operating income by business segment 2020

In fiscal year 2020, the core operating income of Sumitomo Chemical's pharmaceuticals segment amounted to around 71.7 billion Japanese yen. That year, the total core operating income of the company reached approximately 147.6 billion Japanese yen.
Founded in 1913 and headquartered in Tokyo and Osaka Prefecture, Sumitomo Chemical is a Japanese chemical company operating in several business sectors such as the health and crop science, pharmaceutical and energy industries.

Core operating income of Sumitomo Chemical Co., Ltd. in fiscal year 2020, by business segment (in billion Japanese yen)

Characteristic	Core operating income in billion Japanese yen
Pharmaceuticals	71.67
IT-related chemicals	39.73
Health and crop sciences	31.55
Energy and functional materials	20.27
Others	12.75
Petrochemicals and plastics	-11.99

Loading statistic...

Download

Source

Show detailed source information?

Already a member?

Source

Use Ask Statista Research Service

Release date

September 2021

More information

Region

Japan

Survey time period

fiscal year 2020; the Japanese fiscal year starts on April 1 of the stated year and ends on March 31 of the following year

Supplementary notes

Starting from fiscal 2017, the Sumitomo Chemical Group has adopted international financial reporting standards (IFRS) in place of Japanese GAAP, which was previously used, and therefore restated figures for the previous consolidated fiscal year using IFRS for comparative analysis.

100 Japanese yen equal 0.74 U.S. dollars or 0.70 euros as of December 2022.
Figures have been rounded.

Citation formats